Advances in the Management of Pancreatic Adenocarcinoma |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Cardiovascular Health and Risk Management in Cancer Survivors |
0.50 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Current Topics in Management of Non-Muscle Invasive Bladder Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Emerging Treatment Options for the Management of Metastatic Colorectal Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Implementing Clinical Trials in the Community Setting |
0.50 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Management of Gliomas: Individualized Treatment Options |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Management of Metastatic Breast Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Multidisciplinary Management of Advanced Kidney Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Novel and Emerging Treatment Strategies for Acute Myeloid Leukemia |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Recent Developments in the Management of Prostate Cancer |
0.50 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Role of Biomarkers in Individualizing Treatment Selection for Patients with Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Role of Biosimilars in the Oncology Ecosystem |
1.25 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Debate - What is Optimal First-Line Therapy for Chronic Lymphocytic Leukemia: Chemoimmunotherapy or Small Molecule Inhibitor Therapy? |
1.25 |
05/18/2020 - 12:00am to 03/01/2021 - 12:00am |
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia |
0.75 |
05/20/2020 - 12:00am to 05/20/2021 - 12:00am |
A Practical Approach to the Diagnosis and Treatment of Anemia in Cancer Patients |
1.00 |
05/20/2020 - 12:00am to 03/01/2021 - 12:00am |